Successful treatment of early onset Epstein-Barr virus-negative T-cell lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation with histone deacetylase inhibitor chidamide

Chin Med J (Engl). 2021 Apr 14;134(22):2756-2758. doi: 10.1097/CM9.0000000000001488.

Hua-Rui Fu^{1

2

3}, Ting-Ting Yang⁴, Yan-Min Zhao^{1

2

3}, Ya-Min Tan^{1

2

3}, Qi-Qi Gao⁵, He Huang^{1

2

3}, Ji-Min Shi^{1

2

3}

¹ Department of Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China.
² Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang 310003, China.
³ Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou, Zhejiang 310003, China.
⁴ Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China.
⁵ Department of Pathology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China.

No abstract available

Publication types